Association of serum cholesterol and cholesterol-lowering drug use with serum sex steroid hormones in men in NHANES III
- 29 May 2010
- journal article
- research article
- Published by Springer Nature in Cancer Causes & Control
- Vol. 21 (10) , 1575-1583
Abstract
Purpose Low cholesterol levels and statin drugs may protect against prostate cancer with a worse prognosis. Their protective mechanism is unknown, but has been hypothesized to be related to cholesterol’s role as a sex steroid hormone precursor. We evaluated whether serum testosterone and estradiol differ by cholesterol or cholesterol-lowering drug use. Materials and methods Testosterone and estradiol were measured for 1,457 male participants in the Third National Health and Nutrition Examination Survey. We estimated multivariable-adjusted geometric mean hormone concentration by quintiles of cholesterol concentration and by cholesterol-lowering drugs use. Results Across quintiles of cholesterol, testosterone level did not differ (mean, 95% confidence interval (CI); Q1: 5.25, 5.02–5.49, Q5: 5.05, 4.76–5.37 ng/ml; p-trend = 0.32), whereas estradiol levels were lower (Q1: 38.7, 36.9–40.5; Q5: 33.1, 31.8–34.5 pg/ml; p-trend < 0.0001). Neither testosterone (no: 5.12, 4.94–5.30, yes: 4.91, 4.33–5.57 ng/ml, p = 0.57) nor estradiol (no: 35.9, 34.8–37.1; yes: 33.9, 29.4–39.2 pg/ml; p = 0.39) differed by cholesterol-lowering drugs use. Conclusion Testosterone did not differ by cholesterol or cholesterol-lowering drug use. Estradiol was lower in men with higher cholesterol, but did not differ by cholesterol-lowering drug use. Our results suggest that the lower risk of advanced prostate cancer among statin users is not readily explained by a cholesterol-mediated effect of statins on sex hormone levels.Keywords
This publication has 55 references indexed in Scilit:
- Statins and cancer preventionNature Reviews Cancer, 2005
- Hormonal changes with cholesterol reduction: a double-blind pilot studyJournal of Clinical Pharmacy and Therapeutics, 2004
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Testicular Function in Hypercholesterolemic Male Patients During Prolonged Simvastatin TreatmentHormone and Metabolic Research, 1996
- Prospective Case Control Study to Determine the Effect of Lovastatin on Serum Testosterone and Cortisol Concentrations in Hyperlipidemic Nephrotic Patients with Chronic Renal FailureNephron, 1996
- Sustained therapy with 3-hydroxy-3-methylglutaryl-coenzyme-A reductase inhibitors does not impair steroidogenesis by adrenals and gonadsThe Journal of Clinical Endocrinology & Metabolism, 1995
- Relationship of sex hormones to lipids and lipoproteins in nondiabetic menThe Journal of Clinical Endocrinology & Metabolism, 1993
- Relationships of plasma lipoprotein concentrations to unbound, albumin-bound and sex hormone-binding globulin-bound fractions of gonadal steroids in menEuropean Journal of Clinical Investigation, 1989
- Determinants of lipid and lipoprotein level in elderly menAtherosclerosis, 1986
- Relation between plasma high-density lipoprotein cholesterol and sex hormone concentrations in menThe American Journal of Cardiology, 1984